Benzinga | Aug 11, 2021 04:10PM EDT

TELA Bio Q2 EPS $(0.57) Misses $(0.52) Estimate, Sales $7.56M Beat $6.31M Estimate

TELA Bio (NASDAQ:TELA) reported quarterly losses of $(0.57) per share which missed the analyst consensus estimate of $(0.52) by 9.62 percent. This is a 7.55 percent decrease over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $7.56 million which beat the analyst consensus estimate of $6.31 million by 19.78 percent. This is a 115.51 percent increase over sales of $3.51 million the same period last year.